AgilityBio and Advinus focus on preclinical imaging
AgilityBio, a division of BioImagene, and Advinus Therapeutics, have teamed up to bolt on imaging services to the latter’s existing preclinical development offering.
Archives for October 22, 2008
Sanofi invests in Chinese clinical R&D capacity
French drug giant Sanofi-Aventis has set its sights on developing China as its Asian R&D hub, unveiling plans for a significant expansion of its clinical research unit in Shanghai.
Self-assembling hydrogel for drug delivery
Researchers have developed a self-assembling hydrogel, which they claim is biocompatible, easy to tailor and efficient at releasing drugs.
GAO critical of FDA’s overseas inspections
A report has been published detailing the US Food and Drug Administration’s (FDA) failings in its inspection of overseas manufacturing facilities.
Azopharma adds microdosing to service portfolio
Contract drug development company Azopharma Product Development has set up a new business unit to cater for companies wanting to run microdosing or so-called Phase 0 studies.
Borgas sets out ‘top 8’ pharma industry issues
The pharmaceutical industry must adapt its processes and strategies to cope with a new, tougher operating environment, according to Stefan Borgas, CEO of Lonza.
Merck must axe a further 7,200 jobs “to survive,” says CEO
Merck & Co plans to cut 7,200 jobs, joining the growing list of big pharma firms enacting restructuring measures in the face of falling earnings and an uncertain market future.
UK clinical trials too bureaucratic, say experts
Increasing bureaucracy in clinical research in the UK is posing a threat to the industry, according to a report published in the British Medical Journal.